期刊文献+

提高蛋白多肽口服生物利用度的方法 被引量:1

Approaches for Enhancing Oral Bioavailability of Peptides and Proteins
原文传递
导出
摘要 综述了常用的提高蛋白多肽生物利用度的策略,包括化学修饰、吸收促进剂、粘膜粘附系统、脂质体和纳微球等,系统分析了各种策略的研究现状及优缺点,重点分析了纳微球的研究现状.指出在纳微球的基础上对影响药物释放和吸收的各方面因素进行系统化、个性化设计,有望设计出可应用于临床的蛋白多肽口服给药系统. The approaches for enhancing oral bioavailability of biomacromolecules, such as peptides and proteins, including chemical modification, absorption enhancers, mucoadhesive systems, liposomes and nano-microparticles are comprehensively reviewed, and the status of these approaches and their relative merits analyzed, focusing on the status of nano-microparticles. Finally, it is pointed out that on the basis of nano-microparticles, analyzing and designing all aspects of drug release and absorption systematically and personally, oral drug delivery system ofpeptides and proteins for clinical applications is expected to construct.
出处 《过程工程学报》 CAS CSCD 北大核心 2014年第2期354-360,共7页 The Chinese Journal of Process Engineering
基金 国家自然科学基金资助项目(编号:81202487)
关键词 蛋白多肽 口服给药 生物利用度 强化 protein and peptide oral delivery bioavailability enhancement
  • 相关文献

参考文献71

  • 1Craik D J, Fairlie D P, Liras S, et al. The Future of Peptide-based Drugs[J].Chemical Biology & Drug Design, 2013, 81(1): 136-147.
  • 2李娟,赵维纲.口服胰岛素制剂研发进展[J].中国新药杂志,2011,20(21):2095-2099. 被引量:8
  • 3Hoffinan A, Ziv E. Phannacokinetic Considerations of New Insulin Formulations and Routes of Administration[J].Clinical Pharmacokinetics, 1997,33(4): 285-301.
  • 4Ezharul H C. Oral Nano-insulin Therapy: Current Progress on Nanoparticle-based Devices for Intestinal Epithelium-targeted Insulin Delivery[J].Journal of Nanomedicine & Nanotechnology, 2012, doi: 10.4172/2157-7439. S4-007.
  • 5Lee H J. Protein Drug Oral Delivery: The Recent Progress[J].Arch. Pharmacal Res., 2002, 25(5): 572-584.
  • 6Jain A, Jain A, Gulbake A, et al. Peptide and Protein Delivery Using New Drug Delivery Systems[J].Critical Reviews? in Therapeutic Drug Carrier Systems, 2013, 30(4): 293-329.
  • 7Yun Y, Cho Y W, Park K. Nanoparticles for Oral Delivery: Targeted Nanoparticles with Peptidic Ligands for Oral Protein Delivery[J].Advanced Drug Delivery Reviews, 2013, 65(6): 822-832.
  • 8Kammona 0, Kiparissides C. Recent Advances in Nanocarrier Based Mucosal Delivery of Biomolecules[J]. J. Controlled Release, 2012, 161(3): 781-794.
  • 9Frokjaer S, Otzen D E. Protein Drug Stability: A Formulation Challenge[J].Nature Reviews Drug Discovery, 2005, 4(4): 298-306.
  • 10Wang J, Chow D, Heiati H, et al. Reversible Lipidization for the Oral Delivery of Salmon Calcitonin[J]. J. Controlled Release, 2003, 88(3): 369-380.

二级参考文献58

共引文献32

同被引文献2

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部